Biovaxys Technology Corp Stock Total Debt
| BVAXF Stock | USD 0.05 0.01 11.78% |
Biovaxys Technology Corp fundamentals help investors to digest information that contributes to Biovaxys Technology's financial success or failures. It also enables traders to predict the movement of Biovaxys OTC Stock. The fundamental analysis module provides a way to measure Biovaxys Technology's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Biovaxys Technology otc stock.
Biovaxys |
Biovaxys Technology Corp OTC Stock Total Debt Analysis
Biovaxys Technology's Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
| Competition |
Based on the latest financial disclosure, Biovaxys Technology Corp has a Total Debt of 0.0. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Biotechnology industry. The total debt for all United States stocks is 100.0% higher than that of the company.
Biovaxys Total Debt Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Biovaxys Technology's direct or indirect competition against its Total Debt to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Biovaxys Technology could also be used in its relative valuation, which is a method of valuing Biovaxys Technology by comparing valuation metrics of similar companies.Biovaxys Technology is currently under evaluation in total debt category among its peers.
Biovaxys Fundamentals
| Return On Equity | -0.73 | |||
| Return On Asset | -0.38 | |||
| Current Valuation | 11.35 M | |||
| Shares Outstanding | 106.72 M | |||
| Shares Owned By Insiders | 18.94 % | |||
| Price To Earning | (4.32) X | |||
| Price To Book | 2.53 X | |||
| EBITDA | (6.44 M) | |||
| Net Income | (6.46 M) | |||
| Cash And Equivalents | 39.05 K | |||
| Current Ratio | 0.16 X | |||
| Book Value Per Share | 0.06 X | |||
| Cash Flow From Operations | (5.29 M) | |||
| Earnings Per Share | (0.05) X | |||
| Number Of Employees | 17 | |||
| Beta | -0.59 | |||
| Market Capitalization | 8.73 M | |||
| Total Asset | 8.5 M | |||
| Retained Earnings | (80 M) | |||
| Working Capital | 35 M | |||
| Current Asset | 37 M | |||
| Current Liabilities | 2 M | |||
| Z Score | -7.8 | |||
| Net Asset | 8.5 M |
About Biovaxys Technology Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Biovaxys Technology Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biovaxys Technology using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biovaxys Technology Corp based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Biovaxys OTC Stock
Biovaxys Technology financial ratios help investors to determine whether Biovaxys OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biovaxys with respect to the benefits of owning Biovaxys Technology security.